| | EN
Corporate Information
Company Name:
Raily Aesthetic Medicine International Holdings Limited
Headquarters and principal place of business in the PRC:
3–5/F, Minhang Tower, No. 290 North Zhongshan Road, Gongshu District, Hangzhou City, PRC
Principal place of business in Hong Kong:
17/F, Leighton Centre, 77 Leighton Road, Causeway Bay,Hong Kong
Company secretary:
Mr. Chan Oi Fat (陳愛發)
Authorized representatives:
Mr. Fu Haishu (傅海曙)
Mr. Chan Oi Fat (陳愛發)
Audit Committee:
Mr. Liu Teng (劉騰) (Chairperson)
Mr. Cao Dequan (曹德全)
Ms. Yang Xiaofen (楊小芬)
Nomination Committee:
Mr. Fu Haishu (傅海曙) (Chairperson)
Mr. Cao Dequan (曹德全)
Ms. Yang Xiaofen (楊小芬)
Remuneration Committee:
Mr. Cao Dequan (曹德全) (Chairperson)
Mr. Fu Haishu (傅海曙)
Mr. Liu Teng (劉騰)
Prospectus
Financial Reports
Announcements and Circulars
Corporate Governance

Board Committees:
The Group has established the following committees within the Board of Directors: an audit committee, a remuneration committee and a nomination committee. The committees operate in accordance with the terms of reference established by the Board of Directors and Rule 3.21 and Rule 3.25 of the Listing Rules.

Audit Committee:
The Group has established an audit committee with written terms of reference in compliance with Rule 3.21 of the Listing Rules and the paragraph C.3 of the Corporate Governance Code as set forth in Appendix 14 of the Listing Rules. The audit committee consists of three members, namely, Mr. Liu Teng, Mr. Cao Dequan and Ms. Yang Xiaofen. Mr. Liu Teng, with appropriate accounting and financial management expertise, is the chairman of the committee. The primary duties of the audit committee are to provide oversight of the financial reporting process, the audit process, the mechanism of internal control and compliance with laws and regulations and perform further duties and responsibilities as assigned by the Board from time to time.

Remuneration Committee:
The Group has established a remuneration committee with written terms of reference in compliance with Rule 3.25 of the Listing Rules and the paragraph B.1 of the Corporate Governance Code as set out in Appendix 14 of the Listing Rules. The remuneration committee consists of three members, namely, Mr. Cao Dequan, Mr. Fu Haishu and Mr. Liu Teng. Mr. Cao Dequan is the chairman of the committee. The primary duties of the Remuneration Committee are to make recommendations to the Board regarding the policy and structure for the remuneration of the Directors and senior management and on the establishment of a formal and transparent procedure for developing remuneration policies, and to make recommendations to the Board on the remuneration packages of the Directors and senior management and on the employee benefit arrangement.

Nomination Committee:
The Group has established a nomination committee with written terms of reference in compliance with the paragraph A.5 of the Corporate Governance Code as set forth in Appendix 14 of the Listing Rules. The nomination committee consists of three members, namely, Mr. Fu Haishu, Mr. Cao Dequan and Ms. Yang Xiaofen. Mr. Fu Haishu is the chairman of the committee. The primary duties of the nomination committee are to make recommendations to the Board in relation to the appointment and removal of Directors and senior management and on matters of succession planning.

Check out:
《PROCEDURES FOR SHAREHOLDERS TO PROPOSE A PERSON FOR ELECTION AS A DIRECTOR》《Dissemination of Corporate Communications》

Investor Enquiries
Raily Aesthetic Medicine International Holdings Limited
Address: 3–5/F, Minhang Tower, No. 290 North Zhongshan Road, Gongshu district, Hangzhou City, PRC
Tel:0571-88826555
Fax:0571-88827555
Email: investor.relationship@raily.com
© 2021 Raily Aesthetic Medicine International Holdings Limited. All Rights Reserved.备案号:浙ICP备2021020053号-1